Human TNFRSF13C/BAFF-R/BAFFR ORF/cDNA clone-Lentivirus plasmid (NM_052945)
Cat. No.: pGMLP004528
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human TNFRSF13C/BAFF-R/BAFFR Lentiviral expression plasmid for TNFRSF13C lentivirus packaging, TNFRSF13C lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
TNFRSF13C/CD268/TNFRSF13C/BAFF-R products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP004528 |
| Gene Name | TNFRSF13C |
| Accession Number | NM_052945 |
| Gene ID | 115650 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 555 bp |
| Gene Alias | BAFF-R,BAFFR,BROMIX,CD268,CVID4,prolixin |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAGGCGAGGGCCCCGGAGCCTGCGGGGCAGGGACGCGCCAGCCCCCACGCCCTGCGTCCCGGCCGAGTGCTTCGACCTGCTGGTCCGCCACTGCGTGGCCTGCGGGCTCCTGCGCACGCCGCGGCCGAAACCGGCCGGGGCCAGCAGCCCTGCGCCCAGGACGGCGCTGCAGCCGCAGGAGTCGGTGGGCGCGGGGGCCGGCGAGGCGGCGCTGCCCCTGCCCGGGCTGCTCTTTGGCGCCCCCGCGCTGCTGGGCCTGGCACTGGTCCTGGCGCTGGTCCTGGTGGGTCTGGTGAGCTGGAGGCGGCGACAGCGGCGGCTTCGCGGCGCGTCCTCCGCAGAGGCCCCCGACGGAGACAAGGACGCCCCAGAGCCCCTGGACAAGGTCATCATTCTGTCTCCGGGAATCTCTGATGCCACAGCTCCTGCCTGGCCTCCTCCTGGGGAAGACCCAGGAACCACCCCACCTGGCCACAGTGTCCCTGTGCCAGCCACAGAGCTGGGCTCCACTGAACTGGTGACCACCAAGACGGCCGGCCCTGAGCAACAATAG |
| ORF Protein Sequence | MRRGPRSLRGRDAPAPTPCVPAECFDLLVRHCVACGLLRTPRPKPAGASSPAPRTALQPQESVGAGAGEAALPLPGLLFGAPALLGLALVLALVLVGLVSWRRRQRRLRGASSAEAPDGDKDAPEPLDKVIILSPGISDATAPAWPPPGEDPGTTPPGHSVPVPATELGSTELVTTKTAGPEQQ |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-256 | Pre-Made Ianalumab biosimilar, Whole mAb, Anti-TNFRSF13C Antibody: Anti-BAFF-R/BAFFR/BROMIX/CD268/CVID4/prolixin therapeutic antibody |
| Target Antibody | GM-Tg-g-T83687-Ab | Anti-TR13C/ TNFRSF13C/ BAFF-R monoclonal antibody |
| Target Antigen | GM-Tg-g-T83687-Ag | TNFRSF13C VLP (virus-like particle) |
| Cytokine | cks-Tg-g-GM-T83687 | tumor necrosis factor receptor superfamily, member 13C (TNFRSF13C) protein & antibody |
| ORF Viral Vector | pGMLP004528 | Human TNFRSF13C Lentivirus plasmid |
| ORF Viral Vector | vGMLP004528 | Human TNFRSF13C Lentivirus particle |
Target information
| Target ID | GM-T83687 |
| Target Name | TNFRSF13C/CD268 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
115650 |
| Gene ID |
100070724 (Equus caballus), 101090370 (Felis catus), 115650 (Homo sapiens), 500910 (Rattus norvegicus) 607785 (Canis lupus familiaris), 618516 (Bos taurus), 712577 (Macaca mulatta), 72049 (Mus musculus) |
| Gene Symbols & Synonyms | TNFRSF13C,Tnfrsf13c,BAFF-R,BAFFR,CD268,CVID4,BROMIX,prolixin,RGD1560810,Bcmd,Baffr,Bcmd1,Bcmd-1,Lvis22,2010006P15Rik |
| Target Alternative Names | 2010006P15Rik,B-cell-activating factor receptor,BAFF receptor (BAFF-R),BAFF-R,BAFFR,BLyS receptor 3,BROMIX,Baffr,Bcmd,Bcmd-1,Bcmd1,CD268,CVID4,Lvis22,RGD1560810,TNFRSF13C,Tnfrsf13c,Tumor necrosis factor receptor superfamily member 13C,prolixin |
| Uniprot Accession |
Q96RJ3,Q9D8D0
Additional SwissProt Accessions: Q96RJ3,Q9D8D0 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target |
| Disease | |
| Disease from KEGG | Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Human T-cell leukemia virus 1 infection |
| Gene Ensembl | ENSECAG00000031107, ENSG00000159958, ENSMMUG00000052011, ENSMUSG00000068105 |
| Target Classification | Checkpoint-Immuno Oncology |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


